GILD vs MRK
GILD and MRK side by side — valuation & fundamentals (public data).
Key statistics
| Metric | GILDGILEAD SCIENCES, INC. | MRKMerck & Co., Inc. |
|---|---|---|
| Market cap | $165.04B | $317.18B |
| P/E (TTM) | 19.6 | 102.8 |
| P/B | 13.95 | 7.56 |
| P/S | 5.6x | 4.9x |
| Dividend yield | 2.43% | 2.58% |
| Revenue | $30.46B(TTM) | $66.57B(TTM) |
| Revenue growth (YoY) | 2.4% | 1.3% |
| Net income | -$3.24B(TTM) | $3.17B(TTM) |
| Earnings growth (YoY) | 1672.9% | 6.6% |
| EPS, diluted | $-2.65(TTM) | $1.25(TTM) |
| EBIT margin | 34.0% | 34.2% |
| ROE | 71.9% | 43.5% |
| ROIC | 26.7% | 21.6% |
| 1y total return | +23.6% | +64.1% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: GILD vs MRK
| Metric | GILD | MRK |
|---|---|---|
| End value | $19.6K | $31.7K |
| Total return | +95.9% | +216.6% |
| CAGR | +6.7% | +11.8% |
| Volatility | 25.7% | 22.8% |
| Sharpe | 0.23 | 0.43 |
| Sortino | 0.34 | 0.63 |
| Max drawdown | -36.0% | -43.4% |
Based on 2600 common trading days, 2016-04-06 → 2026-08-07 · risk-free 3.87% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)